Amyloid-beta (Aβ1–42)-induced paralysis in Caenorhabditis elegans is reduced through NHR-49/PPARalpha
Autor: | Anne Leiteritz, Uwe Wenzel, Stefan Baumanns |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Agonist biology Amyloid beta Chemistry medicine.drug_class General Neuroscience fungi biology.organism_classification Cell biology 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Nuclear receptor RNA interference biology.protein medicine Signal transduction Receptor Transcription factor 030217 neurology & neurosurgery Caenorhabditis elegans |
Zdroj: | Neuroscience Letters. 730:135042 |
ISSN: | 0304-3940 |
DOI: | 10.1016/j.neulet.2020.135042 |
Popis: | Alzheimer´s disease is a neurodegenerative disorder characterized by the misfolding and aggregation of amyloid β (Aβ). Agonists of peroxisomal proliferator-activated receptors (PPARs) are discussed as anti-amyloidogenic compounds, e.g. due to their cholesterol-lowering activities. In a previous study we have shown in Caenorhabditis elegans expressing human Aβ in muscle cells, that inhibition of steroid-signaling, by RNAi of respective members of the signaling pathway or by reducing cellular cholesterol uptake, both increases the nuclear translocation of the foxo transcription factor DAF-16 and concomitantly reduces Aβ-induced paralysis. Using RNAi in the present study we show that NHR-49/PPARalpha inhibits steroidal-signaling upstream of DAF-9, a cytochrome P450-dependent enzyme which generates dafachronic acids as ligands for the nuclear hormone receptor DAF-12, and upstream of DAF-12 itself. The NHR-49/PPARalpha agonist fenofibrate reduces Aβ-induced paralysis in dependence on nhr-49 and nuclear translocation of DAF-16. In conclusion, activation of NHR-49/PPARalpha inhibits the steroidal-signaling pathway which increases the nuclear translocation of DAF-16 and inhibits the Aβ-induced phenotype in an Alzheimer model of C. elegans. |
Databáze: | OpenAIRE |
Externí odkaz: |